Global Cancer Technology, Inc.
PrivateLast Round
Crowdfunding
Aug 1, 2026
Est. Valuation
$27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Global Cancer Technology, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Private Placement round in June 2021.
Global Cancer Technology, Inc. is a biopharmaceutical company that develops innovative cancer treatments, including small-molecule PI3K inhibitors and remote-controlled drug delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Global Cancer Technology, Inc. Comparables
Compare Global Cancer Technology, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gibson Oncology, LLC | 82% | |
| QurCan Therapeutics | 82% | |
| GlioCure | 81% |
For institutional investors. Book with your work email.
Global Cancer Technology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 1, 2026 | ||||
| VC Round | Jun 2, 2021 | ||||
| Private Placement | Jun 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 48% MoM.
- Aug 1, 2026
Raised capital via crowdfunding.
For institutional investors. Book with your work email.
Global Cancer Technology, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Global Cancer Technology, Inc.'s valuation, stock price, and market status.
Is Global Cancer Technology, Inc. a public or private company?
Global Cancer Technology, Inc. is a private company.
What is the current stock price of Global Cancer Technology, Inc.?
Global Cancer Technology, Inc. is a private company, so its shares have no public market price. Caplight tracks Global Cancer Technology, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Global Cancer Technology, Inc. worth (valuation)?
Global Cancer Technology, Inc.'s valuation is estimated at $27.0M based on funding round data.
Can I buy Global Cancer Technology, Inc. stock?
Global Cancer Technology, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Global Cancer Technology, Inc.'s last funding round?
Global Cancer Technology, Inc.'s most recent funding round was Crowdfunding on August 1, 2026.
Who are the main investors in Global Cancer Technology, Inc.?
Investor information for Global Cancer Technology, Inc. is not publicly disclosed.
Will Global Cancer Technology, Inc. IPO soon?
No public IPO plans have been announced for Global Cancer Technology, Inc..
How can I track Global Cancer Technology, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Global Cancer Technology, Inc.'s shares on secondary markets.